| Application no. and date | 18179796.0 (espacenet) (Federated) (European Patent Register), 20141006 | | Patent/reg. no. and date | DK/EP 3421033, 20220727 | | Publication date | 20190102 | | Priority no. and date | US 201361887574 P, 20131007 | | EP pub. no. and date |
EP 3421033 20190102 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Holdings Ireland
Unlimited Company, Hinterbergstrasse 16
6312 Steinhausen, CH | | Applicant ref. no. | PU016521DKQ | | Inventor | NIKFAR, Faranak, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
KOO, Otilia May Yue, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
TAO, Jing, c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
VARIA, Sailesh A., c/o Bristol-Myers Squibb Company
1 Squibb Drive
New Brunswick, New Jersey 08903, US,
KOTTALA, Niranjan Kumar, Flat 502 PVR Grand Apt. Simon Nagar
Kurmannapalem
AP 530056 Visakhapatnam, IN | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/4418 (2006.01) , A61K 31/5377 (2006.01) , A61K 9/24 (2006.01) , A61P 31/12 (2006.01) , A61P 31/18 (2006.01) , A61P 43/00 (2006.01) | | Title | FORMULERING AF ATAZANAVIR OG COBICISTAT TIL HIV-BEHANDLING | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
